Quebec French Version of the Hayling Sentence Completion Test: Error Scoring Guidelines, Normative Data for Adults and the Elderly and Validation Study in Mild Cognitive Impairment and Alzheimer's Disease

被引:0
|
作者
Macoir, Joel [1 ,2 ]
Lapierre, Veronick [2 ,3 ]
Brouillard, Marie-Michelle [1 ,2 ]
Verreault, Phylicia [2 ,3 ]
Landry, Mariane [2 ,3 ,4 ]
Hudon, Carol [2 ,3 ,4 ]
机构
[1] Univ Laval, Ecole Sci Readaptat, Fac Med, Pavillon Ferdinand Vandry, Quebec City, PQ G1V 0A6, Canada
[2] Ctr Rech CERVO Brain Res Ctr, Quebec City, PQ G1J 2G3, Canada
[3] Univ Laval, Ecole Psychol, Fac Sci Sociales, Quebec City, PQ G1V 0A6, Canada
[4] CERVO Res Ctr, Ctr Rech VITAM, Quebec City, PQ G1J 2G1, Canada
关键词
Hayling sentence completion test; Norms/normative study; Executive functions; Inhibition; INHIBITORY CONTROL; FRONTOTEMPORAL DEMENTIA; ASSOCIATION WORKGROUPS; DIAGNOSTIC GUIDELINES; NATIONAL INSTITUTE; WORKING-MEMORY; OLDER-ADULTS; AGE; DEFICITS; NORMS;
D O I
10.1093/arclin/acaf014
中图分类号
B849 [应用心理学];
学科分类号
040203 ;
摘要
Introduction Deficits in inhibition have been associated with various clinical conditions, including neurodegenerative diseases. The Hayling Sentence Completion Test (HSCT) is an assessment tool commonly used in clinical settings to measure verbal initiation and prepotent verbal response inhibition. Although it is used by numerous clinical and research groups in Quebec, normative data for the HSCT are not yet available for French-Quebec speakers.Objectives The aims of this study were to provide error scoring guidelines and normative data in the adult population of French Quebec for the HSCT-QC (Study 1) and to determine its known-group discriminant validity (Study 2).Results The results of Study 1, based on a sample of 214 healthy individuals aged 50 to 89, indicated that age significantly affected test performance, while educational level and sex did not. As no transformations were able to normalize the score distribution, percentile ranks for HSCT-QC performance were calculated solely based on age. Results from Study 2 demonstrated that the HSCT-QC effectively distinguishes the performance of healthy participants from those with mild cognitive impairment or Alzheimer's disease.Conclusion Norms and psychometric data for the HSCT-QC will be highly beneficial for assessing inhibitory control in French-speaking adults in Quebec, Canada.
引用
收藏
页数:13
相关论文
共 50 条
  • [31] Validation of the free and cued selective reminding test in Moroccan patients with mild cognitive impairment or Alzheimer's disease
    Azdad, Abdelhak
    Benabdeljlil, Maria
    Faris, Mustapha El Alaoui
    JOURNAL OF THE NEUROLOGICAL SCIENCES, 2023, 455
  • [32] Feasibility of Remote Administration of the Uniform Data Set-Version 3 for Assessment of Older Adults With Mild Cognitive Impairment and Alzheimer's Disease
    Sachs, Bonnie C.
    Latham, Lauren A.
    Bateman, James R.
    Cleveland, Mary Jo
    Espeland, Mark A.
    Fischer, Eric
    Gaussoin, Sarah A.
    Leng, Iris
    Rapp, Stephen R.
    Rogers, Samantha
    Shappell, Heather M.
    Williams, Benjamin J.
    Yang, Mia
    Craft, Suzanne
    ARCHIVES OF CLINICAL NEUROPSYCHOLOGY, 2024, 39 (05) : 635 - 643
  • [33] Cognitive and Neuroimaging Profiles in Mild Cognitive Impairment and Alzheimer's Disease: Data from the Spanish Multicenter Normative Studies (NEURONORMA Project)
    Sanchez-Benavides, Gonzalo
    Pena-Casanova, Jordi
    Casals-Coll, Marta
    Gramunt, Nina
    Molinuevo, Jose L.
    Gomez-Anson, Beatriz
    Aguilar, Miguel
    Robles, Alfredo
    Antunez, Carmen
    Martinez-Parra, Carlos
    Frank-Garcia, Anna
    Fernandez-Martinez, Manuel
    Blesa, Rafael
    JOURNAL OF ALZHEIMERS DISEASE, 2014, 41 (03) : 887 - 901
  • [34] Vitamin D in mild cognitive impairment and Alzheimer's disease. A study in older Greek adults
    Mavraki, E.
    Ioannidis, P.
    Tripsianis, G.
    Gioka, T.
    Kolousi, M.
    Vadikolias, K.
    HIPPOKRATIA, 2020, 24 (03) : 120 - 126
  • [35] The Prague Stroop Test: Normative standards in older Czech adults and discriminative validity for mild cognitive impairment in Parkinson's disease
    Bezdicek, Ondrej
    Lukavsky, Jiri
    Stepankova, Hana
    Nikolai, Tomas
    Axelrod, Bradley N.
    Michalec, Jiri
    Ruzicka, Evzen
    Kopecek, Miloslav
    JOURNAL OF CLINICAL AND EXPERIMENTAL NEUROPSYCHOLOGY, 2015, 37 (08) : 794 - 807
  • [36] A Color-Picture Version of Boston Naming Test Outperformed the Black-and-White Version in Discriminating Amnestic Mild Cognitive Impairment and Mild Alzheimer's Disease
    Li, Dan
    Yu, Yue-Yi
    Hu, Nan
    Zhang, Min
    Liu, Li
    Fan, Li-Mei
    Ruan, Shi-Shuang
    Wang, Fen
    FRONTIERS IN NEUROLOGY, 2022, 13
  • [37] Three plasma metabolites in elderly patients differentiate mild cognitive impairment and Alzheimer's disease: a pilot study
    Costa, Alana C.
    Joaquim, Helena P. G.
    Forlenza, Orestes, V
    Gattaz, Wagner F.
    Talib, Leda L.
    EUROPEAN ARCHIVES OF PSYCHIATRY AND CLINICAL NEUROSCIENCE, 2020, 270 (04) : 483 - 488
  • [38] Three plasma metabolites in elderly patients differentiate mild cognitive impairment and Alzheimer’s disease: a pilot study
    Alana C. Costa
    Helena P. G. Joaquim
    Orestes V. Forlenza
    Wagner F. Gattaz
    Leda L. Talib
    European Archives of Psychiatry and Clinical Neuroscience, 2020, 270 : 483 - 488
  • [39] Argentine Validation of the Spanish Version of the Montreal Cognitive Assessment Test (MoCA-S) and its usefulness in Mild Cognitive Impairment and Dementia in Elderly.
    Portinari, Carla
    Gaston Graviotto, Hector
    Sorbara, Marcos
    Serrano, Cecilia
    NEUROLOGY, 2020, 94 (15)
  • [40] Validation study of the Alzheimer's disease assessment scale-cognitive subscale (ADAS-Cog) for the Portuguese patients with mild cognitive impairment and Alzheimer's disease
    Nogueira, Joana
    Freitas, Sandra
    Duro, Diana
    Almeida, Jorge
    Santana, Isabel
    CLINICAL NEUROPSYCHOLOGIST, 2018, 32 : 46 - 59